Bioton SA
WSE:BIO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
PetroChina Co Ltd
SSE:601857
|
CN |
|
H
|
Hardwyn India Ltd
NSE:HARDWYN
|
IN |
Bioton SA
Total Current Liabilities
Bioton SA
Total Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
Bioton SA
WSE:BIO
|
Total Current Liabilities
zł102.9m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-7%
|
|
|
M
|
Mabion SA
WSE:MAB
|
Total Current Liabilities
zł42.6m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
5%
|
|
|
R
|
Read Gene SA
WSE:RDG
|
Total Current Liabilities
zł1.3m
|
CAGR 3-Years
16%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-4%
|
|
|
P
|
Pure Biologics SA
WSE:PUR
|
Total Current Liabilities
zł19.9m
|
CAGR 3-Years
20%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
|
U
|
Urteste SA
WSE:URT
|
Total Current Liabilities
zł1.7m
|
CAGR 3-Years
67%
|
CAGR 5-Years
108%
|
CAGR 10-Years
N/A
|
|
|
S
|
Synthaverse SA
WSE:SVE
|
Total Current Liabilities
zł40m
|
CAGR 3-Years
13%
|
CAGR 5-Years
13%
|
CAGR 10-Years
-1%
|
|
Bioton SA
Glance View
BIOTON SA engages in the manufacture and production of medicine and pharmaceutical substances. The company is headquartered in Warsaw, Woj. Mazowieckie and currently employs 371 full-time employees. The company went IPO on 2005-03-16. The firm is engaged in research, development and wholesale trade of pharmaceutical and biotechnological products. The firm's portfolio consists of oral hypoglycemic drugs (metformin and glimepride) as well as recombinant human insulin in pharmaceutical substance form and for injections. Additionally, the Company provides advertising services. As of December 31, 2011, the Company formed a capital group and operated through its subsidiaries, including BIOTON TRADE Sp. z o.o., Mindar Holdings Ltd, Germonta Holdings Ltd, Tricel SA, SciGen Ltd and BioPartners Holdings AG, among others. On June 12, 2014, it sold a 50% stake in Copernicus Sp. z o.o.
See Also
What is Bioton SA's Total Current Liabilities?
Total Current Liabilities
102.9m
PLN
Based on the financial report for Dec 31, 2025, Bioton SA's Total Current Liabilities amounts to 102.9m PLN.
What is Bioton SA's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
-7%
Over the last year, the Total Current Liabilities growth was -28%. The average annual Total Current Liabilities growth rates for Bioton SA have been -10% over the past three years , -8% over the past five years , and -7% over the past ten years .
